Back to Markets
XFX4 Pharmaceuticals Inc

X4 Pharmaceuticals Inc

XFORNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$4.31

+0.1700 (+4.11%)

As of 05/29/26 EDT · USD

Compare
Low: $1.35Current: $4.31High: $4.83

Key Statistics

Open

$4.12

Day High

$4.36

Day Low

$4.05

Prev. Close

$4.14

VolumeShares traded today.

871.33K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$406.52M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-0.94

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$4.83

52W LowLowest price over the past 52 weeks.

$1.35

50D MAAverage closing price over the last 50 trading days.

$4.13

200D MAAverage closing price over the last 200 trading days.

$3.73

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.7%

1M

+5.1%

6M

+13.4%

YTD

+10.8%

1Y

+13.1%

About

Michael "Mike" Weston Bonney is an American businessman and former pharmaceutical executive. Bonney was the president and chief executive officer of Cubist Pharmaceuticals, from 2003 until his retirement in 2014 coinciding with the company being acquired by Merck & Co. for $9.5 billion.

www.x4pharma.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade XFOR

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.